{
    "Trade/Device Name(s)": [
        "proLYTE Electrolyte Analyzer"
    ],
    "Submitter Information": "Diamond Diagnostics",
    "510(k) Number": "K070104",
    "Predicate Device Reference 510(k) Number(s)": [
        "K823480",
        "K000926",
        "K961458",
        "K810615"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JGS",
        "CEM",
        "CGZ"
    ],
    "Summary Letter Date": "April 24, 2008",
    "Summary Letter Received Date": "April 24, 2008",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1665",
        "21CFR862.1600",
        "21CFR862.1170"
    ],
    "Regulation Name(s)": [
        "Sodium Test System",
        "Potassium Test System",
        "Chloride Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Sodium",
        "Potassium",
        "Chloride"
    ],
    "Specimen Type(s)": [
        "Whole Blood",
        "Serum",
        "Plasma",
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "proLYTE Electrolyte Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Potentiometric measurement"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer"
    ],
    "Document Summary": "FDA 510(k) summary for proLYTE Electrolyte Analyzer measuring sodium, potassium, and chloride in whole blood, serum, plasma, and urine",
    "Indications for Use Summary": "In vitro quantitative measurement of sodium, potassium, and chloride in blood, serum, plasma, and urine specimens using potentiometric analysis; analyzer and components do not contact the patient",
    "fda_folder": "Clinical Chemistry"
}